πŸ‡ΊπŸ‡Έ FDA
Patent

US 9096517

Oligomer-containing pyrrolidine compounds

granted A61KA61K31/4015A61K31/765

Quick answer

US patent 9096517 (Oligomer-containing pyrrolidine compounds) held by Nektar Therapeutics expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4015, A61K31/765, A61K47/60